Dieldrin promotes resistance to anoikis in breast cancer cells in vitro

Reproductive Toxicology

Volumn 25, Issue 2, 2008, Pages 256-262

  Cameron, Heather L ^a   Foster, Warren G ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Anoikis; Breast cancer; Dieldrin; Endocrine toxicant; Survival; Tyrosine kinase B

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; DIELDRIN; TUMOR PROMOTER;

ANOIKIS; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER CELL; CANCER CELL CULTURE; CANCER GRADING; CELL LYSATE; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; TUMOR PROMOTION; WESTERN BLOTTING;

ANOIKIS; BREAST NEOPLASMS; CELL LINE, TUMOR; DIELDRIN; FEMALE; HUMANS; INSECTICIDES; RECEPTOR, TRKB;

EID: 39749121408     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2007.11.013     Document Type: Article

References (43)

1. Balzi D., Buiatti E., Geddes M., Khlat M., Masuyer E., and Parkin D.M. Cancer in Italian migrant populations. Summary of the results by site. IARC Sci Publ 123 (1993) 193-292
2. Ziegler R.G., Hoover R.N., Pike M.C., Hildesheim A., Nomura A.M., West D.W., et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 85 22 (1993) 1819-1827
3. Tyczynski J., Tarkowski W., Parkin D.M., and Zatonski W. Cancer mortality among Polish migrants to Australia. Eur J Cancer 30A 4 (1994) 478-484
4. Davis D.L., Bradlow H.L., Wolff M., Woodruff T., Hoel D.G., and Anton-Culver H. Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Perspect 101 5 (1993) 372-377
5. Wolff M.S., and Weston A. Breast cancer risk and environmental exposures. Environ Health Perspect 105 Suppl. 4 (1997) 891-896
6. Hoyer A.P., Jorgensen T., and Grandjean P. Breast cancer and dieldrin. Lancet 356 9244 (2000) 1852-1853
7. Hoyer A.P., Grandjean P., Jorgensen T., Brock J.W., and Hartvig H.B. Organochlorine exposure and risk of breast cancer. Lancet 352 9143 (1998) 1816-1820
8. Jorgenson J.L. Aldrin and dieldrin: a review of research on their production, environmental deposition and fate, bioaccumulation, toxicology, and epidemiology in the United States. Environ Health Perspect 109 Suppl. 1 (2001) 113-139
9. Rogan W.J., and Ragan N.B. Chemical contaminants, pharmacokinetics, and the lactating mother. Environ Health Perspect 102 Suppl. 11 (1994) 89-95
10. Quintana P.J., Delfino R.J., Korrick S., Ziogas A., Kutz F.W., Jones E.L., et al. Adipose tissue levels of organochlorine pesticides and polychlorinated biphenyls and risk of non-Hodgkin's lymphoma. Environ Health Perspect 112 8 (2004) 854-861
11. Glynn A.W., Granath F., Aune M., Atuma S., Darnerud P.O., Bjerselius R., et al. Organochlorines in Swedish women: determinants of serum concentrations. Environ Health Perspect 111 3 (2003) 349-355
12. Davies K. Concentrations and dietary intake of selected organochlorines, including PCBs, PCDDs and PCDFs in fresh food composites grown in Ontario, Canada. Chemosphere 17 2 (1988) 263-276
13. Hoyer A.P., Jorgensen T., Brock J.W., and Grandjean P. Organochlorine exposure and breast cancer survival. J Clin Epidemiol 53 3 (2000) 323-330
14. Frisch S.M., and Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124 4 (1994) 619-626
15. Streuli C.H., and Gilmore A.P. Adhesion-mediated signaling in the regulation of mammary epithelial cell survival. J Mammary Gland Biol Neoplasia 4 2 (1999) 183-191
16. Douma S., Van Laar T., Zevenhoven J., Meuwissen R., Van Garderen E., and Peeper D.S. Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature 430 7003 (2004) 1034-1039
17. Shibayama E., and Koizumi H. Cellular localization of the Trk neurotrophin receptor family in human non-neuronal tissues. Am J Pathol 148 6 (1996) 1807-1818
18. Liotta L.A., and Kohn E. Anoikis: cancer and the homeless cell. Nature 430 7003 (2004) 973-974
19. Nakamura K., Martin K.C., Jackson J.K., Beppu K., Woo C.W., and Thiele C.J. Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1alpha in neuroblastoma cells. Cancer Res 66 8 (2006) 4249-4255
20. Qiu L., Zhou C., Sun Y., Di W., Scheffler E., Healey S., et al. Crosstalk between EGFR and TrkB enhances ovarian cancer cell migration and proliferation. Int J Oncol 29 4 (2006) 1003-1011
21. Miknyoczki S.J., Lang D., Huang L., Klein-Szanto A.J., Dionne C.A., and Ruggeri B.A. Neurotrophins and Trk receptors in human pancreatic ductal adenocarcinoma: expression patterns and effects on in vitro invasive behavior. Int J Cancer 81 3 (1999) 417-427
22. Ricci A., Graziano P., Mariotta S., Cardillo G., Sposato B., Terzano C., et al. Neurotrophin system expression in human pulmonary carcinoid tumors. Growth Factors 23 4 (2005) 303-312
23. Andersen H.R., Vinggaard A.M., Rasmussen T.H., Gjermandsen I.M., and Bonefeld-Jorgensen E.C. Effects of currently used pesticides in assays for estrogenicity, androgenicity, and aromatase activity in vitro. Toxicol Appl Pharmacol 179 1 (2002) 1-12
24. Wassermann M., Nogueira D.P., Tomatis L., Mirra A.P., Shibata H., Arie G., et al. Organochlorine compounds in neoplastic and adjacent apparently normal breast tissue. Bull Environ Contam Toxicol 15 4 (1976) 478-484
25. Haapasalo A., Koponen E., Hoppe E., Wong G., and Castren E. Truncated trkB. T1 is dominant negative inhibitor of trkB. TK+-mediated cell survival. Biochem Biophys Res Commun 280 5 (2001) 1352-1358
26. Atwal J.K., Massie B., Miller F.D., and Kaplan D.R. The TrkB-Shc site signals neuronal survival and local axon growth via MEK and P13-kinase. Neuron 27 2 (2000) 265-277
27. Obermeier A., Lammers R., Wiesmuller K.H., Jung G., Schlessinger J., and Ullrich A. Identification of Trk binding sites for SHC and phosphatidylinositol 3′-kinase and formation of a multimeric signaling complex. J Biol Chem 268 31 (1993) 22963-22966
28. Perez-Pinera P., Hernandez T., Garcia-Suarez O., de Carlos F., Germana A., Del Valle M., et al. The Trk tyrosine kinase inhibitor K252a regulates growth of lung adenocarcinomas. Mol Cell Biochem 295 (2007) 19-26
29. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 1 (2000) 57-70
30. Frisch S.M., and Ruoslahti E. Integrins and anoikis. Curr Opin Cell Biol 9 5 (1997) 701-706
31. Reginato M.J., Mills K.R., Paulus J.K., Lynch D.K., Sgroi D.C., Debnath J., et al. Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis. Nat Cell Biol 5 8 (2003) 733-740
32. Wang P., Valentijn A.J., Gilmore A.P., and Streuli C.H. Early events in the anoikis program occur in the absence of caspase activation. J Biol Chem 278 22 (2003) 19917-19925
33. Shibata M.A., Liu M.L., Knudson M.C., Shibata E., Yoshidome K., Bandey T., et al. Haploid loss of Bax leads to accelerated mammary tumor development in C3(1)/SV40-TAg transgenic mice: reduction in protective apoptotic response at the preneoplastic stage. EMBO J 18 10 (1999) 2692-2701
34. Krajewski S., Blomqvist C., Franssila K., Krajewska M., Wasenius V.M., Niskanen E., et al. Reduced expression of proapoptotic gene Bax is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res 55 19 (1995) 4471-4478
35. Derksen P.W., Liu X., Saridin F., van der G.H., Zevenhoven J., Evers B., et al. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 10 5 (2006) 437-449
36. Raval G.N., Bharadwaj S., Levine E.A., Willingham M.C., Geary R.L., Kute T., et al. Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors. Oncogene 22 40 (2003) 6194-6203
37. Dionne C.A., Camoratto A.M., Jani J.P., Emerson E., Neff N., Vaught J.L., et al. Cell cycle-independent death of prostate adenocarcinoma is induced by the trk tyrosine kinase inhibitor CEP-751 (KT6587). Clin Cancer Res 4 8 (1998) 1887-1898
38. Eggert A., Grotzer M.A., Ikegaki N., Zhao H., Cnaan A., Brodeur G.M., et al. Expression of the neurotrophin receptor TrkB is associated with unfavorable outcome in Wilms' tumor. J Clin Oncol 19 3 (2001) 689-696
39. Pearse R.N., Swendeman S.L., Li Y., Rafii D., and Hempstead B.L. A neurotrophin axis in myeloma: TrkB and BDNF promote tumor-cell survival. Blood 105 11 (2005) 4429-4436
40. Byrne C., Schairer C., Brinton L.A., Wolfe J., Parekh N., Salane M., et al. Effects of mammographic density and benign breast disease on breast cancer risk (United States). Cancer Causes Control 12 2 (2001) 103-110
41. Celis J.E., Moreira J.M., Cabezon T., Gromov P., Friis E., Rank F., et al. Identification of extracellular and intracellular signaling components of the mammary adipose tissue and its interstitial fluid in high risk breast cancer patients: toward dissecting the molecular circuitry of epithelial-adipocyte stromal cell interactions. Mol Cell Proteomics 4 4 (2005) 492-522
42. Klaunig J.E., Xu Y., Bachowski S., Ketcham C.A., Isenberg J.S., Kolaja K.L., et al. Oxidative stress in nongenotoxic carcinogenesis. Toxicol Lett 82-83 (1995) 683-691
43. Stevenson D.E., Walborg Jr. E.F., and Klaunig J.E. The species specificity of dieldrin- or phenobarbital-induced hepatocarcinogenesis: case studies with implications for human health risk assessment. Prog Clin Biol Res 391 (1995) 337-345